Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

News > All

Total search results: 17091 | Ordered by Source (ascending)
next pagenext page 1 2 3 ... 169 170 171  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
4SC AG. (5/30/13). "Press Release: 4SC Gives Update on the Clinical Development of Its Lead Cancer Compound Resminostat". Planegg-Martinsried. 2013-05-30
4SC AG. (5/31/16). "Press Release: 4SC Enters into Licensing and Development Partnership with Link Health for the Cancer Compound 4SC-205 in China". Planegg-Martinsried. 2016-05-31
4SC AG. (5/8/14). "Press Release: 4SC Announces Financial Results for the First Quarter of 2014". Planegg-Martinsried. 2014-05-08
4SC AG. (5/9/11). "Press Release: 4SC’s Vidofludimus Inhibits IL-17 Production by Interference with the JAK/STAT and NF-kB Pathways". Planegg-Martinsried. 2011-05-09
4SC AG. (6/11/13). "Press Release: UCB to Collaborate with Crelux and 4SC Discovery to Meet Unmet Needs in Neurology". Planegg-Martinsried & Brussels. 2013-06-11
4SC AG. (6/20/13). "Press Release: 4SC Announces Restructuring Associated with Recently Declared Strategic Shift". Planegg-Martinsried. 2013-06-20
4SC AG. (6/23/11). "Press Release: 4SC Reports New Data from the Clinical Trials with Oral Pan-HDAC Inhibitor Resminostat. Update on Phase II SHELTER and Phase I/II SHORE Trials". Planegg-Martinsried. 2011-06-23
4SC AG. (6/28/19). "Press Release: 4SC AG Secures EUR 11 Million from Capital Increase [Ad hoc, not for US, AU, CA, JP, ZA, et al.]". Planegg-Martinsried. 2019-06-28
4SC AG. (6/29/12). "Press Release: 4SC AG Capital Increase. Subscription Offer Period Ended, Rump Placement Started [not for USA, Australia, Canada, Japan et al.]". Planegg-Martinsried. 2012-06-29
4SC AG. (6/29/12). "Press Release: 4SC AG. Volume of the Capital Increase Has Been Determined at 8,403,510 New Shares, Gross Proceeds of EUR 12,605,265.00 Expected [not for USA, Australia, Canada, Japan et al.]". Planegg-Martinsried. 2012-06-29
4SC AG. (6/5/14). "Press Release: 4SC Secures Financing with Shareholder Loan of up to EUR 10 Million". 2014-06-05
4SC AG. (6/8/11). "Press Release: 4SC Announces Topline Results of Phase IIb Trial of Vidofludimus in Rheumatoid Arthritis". Planegg-Martinsried. 2011-06-08
4SC AG. (7/12/11). "Press Release: FDA Grants Orphan Drug Designation to 4SC’s Oral Pan-HDAC Inhibitor Resminostat for the Treatment of Hepatocellular Carcinoma". Planegg-Martinsried. 2011-07-12
4SC AG. (7/17/12). "Press Release: 4SC Discovery, Crelux and Ribological Launch Collaboration for the Discovery and Optimisation of New Anti-cancer Drugs [no US". Planegg-Martinsried. 2012-07-17
4SC AG. (7/18/17). "Press Release: 4SC Licenses Kv1.3 Inhibitors to Maruho. Maruho to Receive Exclusive Worldwide License on 4SC’s Preclinical Inhibitors of the Kv1.3 Ion Channel". Planegg-Martinsried. 2017-07-18
4SC AG. (7/20/16). "Press Release: 4SC Forms International Scientific Expert Panel". Planegg-Martinsried. 2016-07-20
4SC AG. (7/24/14). "Press Release: Crelux and 4SC Discovery Awarded Research Grant for New Epigenetic Cancer Drugs. Project for Identifying New Bromodomain Inhibitors Initiated under the Munich m4 Biotech Cluster Programme". Planegg-Martinsried. 2014-07-24
4SC AG. (7/26/11). "Press Release: European Medicines Agency Adopts Positive Opinion for Orphan Medicinal Product Designation for 4SC’s Resminostat to Treat Hepatocellular Carcinoma". 2011-07-26
4SC AG. (7/29/15). "Press Release: 4SC AG Announces Formal Closing of Capital Increase [Not for United States, Australia, Canada or Japan]". Planegg-Martinsried. 2015-07-29
4SC AG. (7/6/17). "Press Release: 4SC AG Secures EUR 41 Million from Successful Capital Increase [Not for US, AU, CA, JP or ZA]". Planegg-Martinsried. 2017-07-06
4SC AG. (7/7/15). "Press Release: 4SC AG Secures EUR 29 Million from Capital Increase to Finance Planned Clinical Development Programme of Its Cancer Compound Resminostat [ Ad hoc release, not for US, AU, CA or JP]". Planegg-Martinsried. 2015-07-07
4SC AG. (8/1/17). "Press Release: 4SC AG Was Granted a Fundamental Composition of Matter Patent for 4SC-208 for the US". Planegg-Martinsried. 2017-08-01
4SC AG. (8/11/16). "Press Release: 4SC Provides Operational and Financial Update for Q2 and 6M 2016". Planegg-Martinsried. 2016-08-11
4SC AG. (8/18/14). "Press Release: Dr Thomas Werner und Klaus Kühn Announce Resignation for Supervisory Board". 2014-08-18
4SC AG. (8/6/12). "Press Release: 4SC AG further Strengthens Supervisory Board with Experienced Managers from the Pharmaceutical Industry [Not for US, AU, CA, JP et al.]". Planegg-Martinsried. 2012-08-06
4SC AG. (8/7/14). "Press Release: 4SC Announces Financial Results for the First Half of 2014". Planegg-Martinsried. 2014-08-07
4SC AG. (8/8/13). "Press Release: 4SC Reports Second Quarter 2013 Financial Results". Planegg-Martinsried. 2013-08-08
4SC AG. (8/9/11). "Press Release: 4SC Announces Financial Results for the Second Quarter and First Half of 2011". Planegg-Martinsried. 2011-08-09
4SC AG. (8/9/12). "Press Release: 4SC’s Successful Start to the Year Continues in Q2 of 2012 [Not for release, publication or distribution in or into US, AU, CA and JP]". Planegg-Martinsried. 2012-08-09
4SC AG. (8/9/18). "Press Release: 4SC Provides Q2 and H1 2018 Update". Planegg-Martinsried. 2018-08-09
4SC AG. (9/16/10). "Press Release: 4SC Provides Enrolment Update for Phase IIb Rheumatoid Arthritis Study with Vidofludimus (4SC-101)". Planegg-Martinsried. 2010-09-16
4SC AG. (9/17/10). "Press Release: 4SC Presents Initial Data from the Resminostat (4SC-201) Phase II SHELTER Study in Hepatocellular Carcinoma (HCC)". Planegg-Martinsried. 2010-09-17
4SC AG. (9/20/18). "Press Release: Domatinostat Plus Chemotherapy – Overcoming Drug Resistance". Planegg-Martinsried. 2018-09-20
4SC AG. (9/21/16). "Press Release: Dr Jason Loveridge Appointed New CEO of 4SC". Planegg-Martinsried. 2016-09-21
4SC AG. (9/26/11). "Press Release: 4SC’s Resminostat Receives FDA Orphan Drug Status for Hodgkin’s Lymphoma". Planegg-Martinsried. 2011-09-26
4SC AG. (9/26/13). "Press Release: 4SC Discovery and Panoptes Pharma Sign Patent Transfer Agreement for Novel Compound to Treat Severe Eye Diseases". Planegg-Martinsried & Vienna. 2013-09-26
4SC AG. (9/3/14). "Press Release: 4SC AG Issues Second Tranche of Convertible Notes with a Nominal Amount of EUR 500,000 to Yorkville". Planegg-Martinsried. 2014-09-03
4SC AG. (9/6/11). "Press Release: 4SC’s Resminostat Meets Primary Efficacy Endpoint in Phase II Trial in Hodgkin’s Lymphoma. Resminostat Shows Substantial Clinical Benefit in Heavily Pre-treated Relapsed/Regractory HL Patients". Planegg-Martinsried. 2011-09-06
4Teen4 Pharmaceuticals GmbH. (12/5/19). "Press Release: Biotech Startup 4Teen4 Pharmaceuticals Closes EUR 7 Million Series A Financing". Hennigsdorf. 2019-12-05
908 Devices, Inc.. (3/4/15). "Press Release: 908 Devices Announces International Expansion". 2015-03-04
908 Devices, Inc.. (6/2/16). "Press Release: Thermo Fisher Scientific and 908 Devices to Demonstrate Innovative Separation Technology with Industry-Leading Orbitrap Mass Spectrometers at ASMS 2016". 2016-06-02
908 Devices, Inc.. (6/21/16). "Press Release: 908 Devices Announces Significant Investments for Life Science Division Following Series C Funding Round". Boston, MA. 2016-06-21
908 Devices, Inc.. (6/3/19). "Press Release: 908 Devices Broadens the ZipChip Platform, Brings New Capability to Biotherapeutics Researchers". Boston, MA. 2019-06-03
908 Devices, Inc.. (7/25/19). "Press Release: 908 Devices Poised to Modernize Upstream Bioprocess Analytics with a Grant from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)". Boston, MA. 2019-07-25
908 Devices, Inc.. (9/11/13). "Press Release: 908 Devices Receives $7 Million in Series B Funding and Signs Multi-year Development Agreement". Boston, MA. 2013-09-11
A*STAR. (1/22/14). "Press Release: A*STAR Signs Agreement with Nestlé to Strengthen Food & Nutrition R&D in Singapore". 2014-01-22
A*STAR. (8/12/10). "Press Release: A*STAR and Institut Mérieux/bioMérieux Invest S$3m in Tuberculosis Research. Partnership Could Lead to Improved Detection and Treatment of the Highly Infectious Disease that Affects Millions Worldwide". 2010-08-12
A-Mansia Biotech S.A.. (4/27/18). "Press Release: Belgian Microbiome Spin-off A-Mansia Announces €13m First Close of Series A Financing". Louvain-la-Neuve. 2018-04-27
A. M. Pappas & Associates. (9/2/14). "Press Release: Chiesi Launches Venture Capital Fund via Strategic Collaboration with A. M. Pappas & Associates. Strategic Collaboration to Focus on Rare Disease Early Stage Investment Opportunities". Parma & Research 2014-09-02
A. Menarini Industrie Farmaceutiche Riunite S.r.l.. (10/29/12). "Press Release: Menarini Group and Oxford BioTherapeutics Sign Major Strategic Collaboration for the Clinical Development and Manufacture of a Portfolio of Novel Antibody-based Cancer Drugs" 2012-10-29
A. Menarini Industrie Farmaceutiche Riunite S.r.l.. (11/25/14). "Press Release: The Menarini Group. New Molecule against Lymphomas and Solid Tumours". Florence. 2014-11-25
A. Menarini Industrie Farmaceutiche Riunite S.r.l.. (11/28/16). "Press Release: Chugai and Berlin-Chemie – the Menarini Group Announce Global License Agreement for an Anti-cancer Agent, PA799". Tokyo & Florence. 2016-11-28
A. Menarini Industrie Farmaceutiche Riunite S.r.l.. (12/20/16). "Press Release: Menarini Acquires CellSearch Business from American group Janssen Diagnostics, Pioneer in High-tech Cancer Diagnostics". Florence. 2016-12-20
A. Menarini Industrie Farmaceutiche Riunite S.r.l.. (9/11/13). "Press Release: Once Cell in One Billion – the New Italian Technology for Attacking Cancer. Menarini Acquires Silicon Biosystems". Florence. 2013-09-11
Aadi Bioscience, Inc.. (5/8/17). "Press Release: Aadi Bioscience Closes $23 Million in Series A Funding". Pacific Palisades, CA. 2017-05-08
Aastrom Biosciences, Inc.. (4/21/14). "Press Release: Aastrom Announces Definitive Agreement to Acquire Sanofi’s Cell Therapy and Regenerative Medicine Business". Ann Arbor, MI. 2014-04-21
AAVLife. (4/15/14). "Press Release: AAVLife Raises $12 Million in Series A Financing to Advance Gene Therapy for Friedreich’s Ataxia". Paris. 2014-04-15
AB Science S.A.. (11/14/13). "Press Release: Issue of New Shares". Paris. 2013-11-14
AB Science S.A.. (2/27/15). "Press Release: Quarterly Information – Fourth quarter 2014. Turnover up 10% Compared to 2013 Fourth Quarter". Paris. 2015-02-27
AB Science S.A.. (3/27/17). "Press Release: AB Science Announces the Success of a Private Placement [Not for US, CA or JP]". Paris. 2017-03-27
AB Science S.A.. (3/31/17). "Press Release: AB Science Announces the Success of a Private Placement [Not for US, CA or JP]". Paris. 2017-03-31
AB Science S.A.. (4/18/16). "Press Release: AB Science Announces the Success of a Private Placement [Not for Distriubution, Publication, Release, Directly or Indirectly, in the United States, Canada, Australia or Japan]". Paris. 2016-04-18
AB Science S.A.. (4/30/15). "Press Release: 2014 Revenues of 2,099 K€. Clinical Trial with Masitinib in 13 Phase 3 Studies". Paris. 2015-04-30
AB Science S.A.. (5/12/17). "Press Release: AB Science Announces that ANSM Requested the Temporary Suspension of Clinical Studies Conducted in France Following Deviations from Good Clinical Practice (GCP) Standards". Paris. 2017-05-12
AB Science S.A.. (7/24/13). "Press Release: AB Science and Its Partners Receive EUR 8.6 Million as Part of a Project Supported by Bpifrance in Alzheimer’s Disease". 2013-07-23
AB Science S.A.. (8/31/15). "Press Release: Turnover of 1,260K€ in the First Half of 2015, Up 23% when Compared with the First Half of 2014". Paris. 2015-08-31
AB Science S.A.. (9/16/15). "Press Release: Masitinib Receives Orphan Drug Designation for Stomach Cancer from FDA". Paris. 2015-09-16
AB Science S.A.. (9/21/15). "Press Release: AB Science Announces Cessation of Its Rheumatoid Arthritis Study in Order to Focus on Clinical Studies with a Probability of Success Greater than 50%". Paris. 2015-09-21
AB Science S.A.. (9/29/16). "Press Release: Filing of Masitinib in the Treatment of Amyotrophic Lateral Sclerosis (ALS) to the European Medicines Agency (EMA)". Paris. 2016-09-29
AB Sciex (d/b/a Sciex). (10/27/16). "Press Release: Scientists Eradicate Leukemic Stem Cells by Targeting Cell Survival Proteins. Sciex Mass Spectrometry-based Solutions Lead to Leukemia Breakthroughs". Framingham, MA. 2016-10-27
AB Sciex (d/b/a Sciex). (10/28/15). "Press Release: Sciex Partners with University of Manchester to Develop Biomarker Discovery Centre and Multi-Omics Centre for Precision Medicine". Framingham, MA. 2015-10-28
AB Sciex (d/b/a Sciex). (11/09/17). "Press Release: New Method for the Detection of Fipronil Insecticide and Its Associated Metabolites in Eggs and Poultry Launched by Sciex". Warrington. 2017-11-09
AB Sciex (d/b/a Sciex). (12/18/17). "Press Release: Sciex and NofaLab Collaboration Delivers Robust and Sensitive Method for Detecting Multiple Pesticides in a Single Run". Warrington, UK. 2017-12-18
AB Sciex (d/b/a Sciex). (3/2/15). "Press Release: Sciex and Labor Berlin Collaboration to Advance Forensic Testing". Framingham, MA & Darmstadt. 2015-03-02
AB Sciex (d/b/a Sciex). (3/22/17). "Press Release: Sciex Presents Novel QTOF Mass Spectrometry System for Simpler and Faster Biotherapeutics Characterisation". Darmstadt. 2017-03-22
AB Sciex (d/b/a Sciex). (4/10/18). "Press Release: Sciex Launches the Citrine Triple Quad MS/MS Systems in Europe, Bringing Maximal Speed and Sensitivity to Clinical Diagnostics Testing". Darmstadt. 2018-04-10
AB Sciex (d/b/a Sciex). (4/27/15). "Press Release: Experts in Pharma, Clinical Research, Omics, Environmental and Food Testing Meet for SCIEX’s 6th LC-MS/MS Symposium in Berlin". Darmstadt. 2015-04-27
AB Sciex (d/b/a Sciex). (4/7/16). "Press Release: Sciex Sponsored Award Acknowledges Exceptional Contributions to the Field of Electrodriven Separation Techniques. Arnold O. Beckman Medal and Award Presented to Dr. Bohuslav Gaš". Framingham, MA. 2016-04-07
AB Sciex (d/b/a Sciex). (5/18/15). "Press Release: Sciex and the National University of Singapore Faculty of Science Sign a Memorandum of Understanding to Accelerate Cancer Biomarker Discovery in Southeast Asia". Singapore. 2015-05-18
AB Sciex (d/b/a Sciex). (6/1/17). "Press Release: Sciex Announces Innovative Solutions for Customer Success Across Markets at ASMS 2017". Framingham, MA. 2017-06-01
AB Sciex (d/b/a Sciex). (6/1/17). "Press Release: Sciex Launches Its Unrivalled Swath Data Independent Acquisition Technology for Comprehensive Analysis of Food, Forensic and Environmental Samples". Framingham, MA. 2017-06-01
AB Sciex (d/b/a Sciex). (6/13/16). "Press Release: The University of Manchester and Sciex to Open the £18m Stoller Biomarker Discovery Centre on June 14th". Framingham, MA & Manchester. 2016-06-13
AB Sciex (d/b/a Sciex). (6/28/16). "Press Release: Sciex Works with the Francis Crick Institute and the University of Cambridge to Establish the Most Comprehensive Understanding of Metabolism To-date". Framingham, MA. 2016-06-28
AB Sciex (d/b/a Sciex). (6/28/16). "Press Release: The University of Manchester and Sciex Opened the £18m Stoller Biomarker Discovery Centre on June 14th". Framingham, MA & Manchester. 2016-06-28
AB Sciex (d/b/a Sciex). (7/22/15). "Press Release: New Method Addresses the Need for Increased Sensitivity in Halal Meat Authentication to Support Halal Certifications". Framingham, MA. 2015-07-22
AB Sciex (d/b/a Sciex). (7/27/17). "Press Release: Sciex Equipment Is Now Available Through a Wide Range of Flexible Financing Packages via Evosciences". Warrington. 2017-07-27
AB Sciex (d/b/a Sciex). (8/25/16). "Press Release: Sciex to Introduce Benchtop High Resolution Mass Spec for Forensic Toxicology Analysis at TIAFT 2016 Meeting in Brisbane, Australia, Aug 28 – Sep 1, 2016". Singapore. 2016-08-25
AB Sciex (d/b/a Sciex). (8/26/15). "Press Release: Sciex QTRAP 6500 LC-MS/MS System Demonstrates Exceptional Sensitivity and Selectivity in Method Development". Framingham, MA. 2015-08-26
AB Sciex (d/b/a Sciex). (9/13/17). "Press Release: Meet Sciex and Learn about Industrialized Biomarker Research Using SWATH Acquisition at HUPO 2017". Framingham, MA. 2017-09-13
AB Sciex (d/b/a Sciex). (9/15/17). "Press Release: Sciex Announces the Appointment of Inese Lowenstein as President. Former President Jean-Paul Mangeolle to Retire". Framingham, MA. 2017-09-15
AB Sciex (d/b/a Sciex). (9/23/19). "Press Release: Sciex Medical Devices Set to Address the Challenges faced by Brazil’s Clinical Diagnostics Laboratories". São Paulo. 2019-09-23
AB Sciex (d/b/a Sciex). (9/5/19). "Press Release: Sciex Launches Partner Portal to Support Customer Needs Worldwide and Extend Network". Framingham, MA. 2019-09-05
AB Sciex (d/b/a Sciex). (9/6/17). "Press Release: Sciex PA 800 Plus Continues to Deliver Quality Results for Ultimate Confidence in Biologics Characterization Data". Framingham, MA. 2017-09-06
AB Sciex (d/b/a Sciex). (9/8/17). "Press Release: Sciex Launches the Topaz LC-MS/MS System for Clinical Diagnostics in Europe". Warrington, UK. 2017-09-08
AB Sciex. (1/17/13). "Press Release: Mobile Laboratory on European MASStastic Voyage Tour to Roll in 2013 with Analytical Tools from AB Sciex, Phenomenex and Peak Scientific". Framingham, MA, Torrance, CA & Billerica, MA. 2013-01-17
AB Sciex. (1/22/15). "Press Release: European Reference Laboratory Improves Accuracy of Pesticide Detection in Food with AB SCIEX Mass Spectrometry Instrumentation". Warrington. 2015-01-22
AB Sciex. (1/28/14). "Press Release: Halal Meat Authenticity Testing Reassures Consumers of No Pig or Horse Contamination. New LC/MS/MS-based Meat Speciation Method". Framingham, MA. 2014-01-28
AB Sciex. (10/2/14). "Press Release: AB Sciex and Illumina Collaborate to Create World’s First Multi-omics Cloud-computing Environment. Integration of SWATH Apps with BaseSpace". Framingham, MA & San Diego, CA. 2014-10-02
AB Sciex. (10/26/11). "Press Release: AB Sciex Advances Food Safety by Mass Spectrometry with the Industry’s First Verified Method for Allergen Testing". Framingham, MA. 2011-10-26
AB Sciex. (10/4/10). "Press Release: ETH Zurich Develops the World’s First Proteomics MRM Atlas with QTRAP Technology from AB Sciex. Online Database of Mass Spectrometry-based Assays to Accelerate Protein Analysis". Foster City, CA. 2010-10-04
next pagenext page 1 2 3 ... 169 170 171  next pagenext page



Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

» top